However, due to the high level of heterogeneity of GBM samples, statistical analysis of the examined sample group acknowledged significant changes only for CCNB1, CCNA2, PLK1, and AURKA, not for CCND1, CCNE1, and CCNE2 (Fig. 3a). This evidence concerns the gene CCNE2 and glioblastoma.